According to the New York Times, the recent “fiscal cliff” deal was a good deal for drug maker Amgen: Just two weeks after pleading guilty in a major federal fraud case, Amgen, the world’s largest biotechnology firm, scored a largely unnoticed coup on Capitol Hill: Lawmakers inserted a paragraph into the “fiscal cliff” bill that … Continue reading Shameless muckraking at the Times